• FDA approvals Perspective
  • FDA approves Grastek for grass allergies

  • April 15, 2014
  • The FDA has approved the second sublingual immunotherapy agent in 2 weeks, according to a press release.
    Grastek (Timothy Grass Pollen Allergen Extract,...More »